Selected research
Market Analysis & Forecast
Global Riluzole Tablet Market Analysis and Forecast 2026-2032
Market perspective
The global Riluzole Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Riluzole Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Riluzole Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Riluzole Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Riluzole Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Riluzole Tablet include Apotex, Covis Pharma, Glemark Generics, Italfarmaco, Lunan Pharma, Mylan Pharma, Sanofi and Sun Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Riluzole Tablet, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Riluzole Tablet, also provides the sales of main regions and countries. Of the upcoming market potential for Riluzole Tablet, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Riluzole Tablet sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Riluzole Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Riluzole Tablet sales, projected growth trends, production technology, application and end-user industry.
Riluzole Tablet Segment by Company
Apotex
Covis Pharma
Glemark Generics
Italfarmaco
Lunan Pharma
Mylan Pharma
Sanofi
Sun Pharma
Riluzole Tablet Segment by Type
With Film-coated
Without Film-coated
Riluzole Tablet Segment by Application
Hospital
Pharmacy
Riluzole Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Riluzole Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Riluzole Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Riluzole Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Riluzole Tablet in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Riluzole Tablet manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Riluzole Tablet sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- With Film-coated
- Without Film-coated
Applications
- Hospital
- Pharmacy
Companies covered
- Apotex
- Covis Pharma
- Glemark Generics
- Italfarmaco
- Lunan Pharma
- Mylan Pharma
- Sanofi
- Sun Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Riluzole Tablet Market by Type
- 1.2.1 Global Riluzole Tablet Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 With Film-coated
- 1.2.3 Without Film-coated
- 1.3 Riluzole Tablet Market by Application
- 1.3.1 Global Riluzole Tablet Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Pharmacy
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Riluzole Tablet Market Dynamics
- 2.1 Riluzole Tablet Industry Trends
- 2.2 Riluzole Tablet Industry Drivers
- 2.3 Riluzole Tablet Industry Opportunities and Challenges
- 2.4 Riluzole Tablet Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Riluzole Tablet Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Riluzole Tablet Revenue by Region
- 3.2.1 Global Riluzole Tablet Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Riluzole Tablet Revenue by Region (2021-2026)
- 3.2.3 Global Riluzole Tablet Revenue by Region (2027-2032)
- 3.2.4 Global Riluzole Tablet Revenue Market Share by Region (2021-2032)
- 3.3 Global Riluzole Tablet Sales Estimates and Forecasts 2021-2032
- 3.4 Global Riluzole Tablet Sales by Region
- 3.4.1 Global Riluzole Tablet Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Riluzole Tablet Sales by Region (2021-2026)
- 3.4.3 Global Riluzole Tablet Sales by Region (2027-2032)
- 3.4.4 Global Riluzole Tablet Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Riluzole Tablet Revenue by Manufacturers
- 4.1.1 Global Riluzole Tablet Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Riluzole Tablet Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Riluzole Tablet Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Riluzole Tablet Sales by Manufacturers
- 4.2.1 Global Riluzole Tablet Sales by Manufacturers (2021-2026)
- 4.2.2 Global Riluzole Tablet Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Riluzole Tablet Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Riluzole Tablet Sales Price by Manufacturers (2021-2026)
- 4.4 Global Riluzole Tablet Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Riluzole Tablet Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Riluzole Tablet Manufacturers, Product Type & Application
- 4.7 Global Riluzole Tablet Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Riluzole Tablet Market CR5 and HHI
- 4.8.2 2025 Riluzole Tablet Tier 1, Tier 2, and Tier 3
5 Riluzole Tablet Market by Type
- 5.1 Global Riluzole Tablet Revenue by Type
- 5.1.1 Global Riluzole Tablet Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Riluzole Tablet Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Riluzole Tablet Revenue Market Share by Type (2021-2032)
- 5.2 Global Riluzole Tablet Sales by Type
- 5.2.1 Global Riluzole Tablet Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Riluzole Tablet Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Riluzole Tablet Sales Market Share by Type (2021-2032)
- 5.3 Global Riluzole Tablet Price by Type
6 Riluzole Tablet Market by Application
- 6.1 Global Riluzole Tablet Revenue by Application
- 6.1.1 Global Riluzole Tablet Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Riluzole Tablet Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Riluzole Tablet Revenue Market Share by Application (2021-2032)
- 6.2 Global Riluzole Tablet Sales by Application
- 6.2.1 Global Riluzole Tablet Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Riluzole Tablet Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Riluzole Tablet Sales Market Share by Application (2021-2032)
- 6.3 Global Riluzole Tablet Price by Application
7 Company Profiles
- 7.1 Apotex
- 7.1.1 Apotex Company Information
- 7.1.2 Apotex Business Overview
- 7.1.3 Apotex Riluzole Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Apotex Riluzole Tablet Product Portfolio
- 7.1.5 Apotex Recent Developments
- 7.2 Covis Pharma
- 7.2.1 Covis Pharma Company Information
- 7.2.2 Covis Pharma Business Overview
- 7.2.3 Covis Pharma Riluzole Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Covis Pharma Riluzole Tablet Product Portfolio
- 7.2.5 Covis Pharma Recent Developments
- 7.3 Glemark Generics
- 7.3.1 Glemark Generics Company Information
- 7.3.2 Glemark Generics Business Overview
- 7.3.3 Glemark Generics Riluzole Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Glemark Generics Riluzole Tablet Product Portfolio
- 7.3.5 Glemark Generics Recent Developments
- 7.4 Italfarmaco
- 7.4.1 Italfarmaco Company Information
- 7.4.2 Italfarmaco Business Overview
- 7.4.3 Italfarmaco Riluzole Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Italfarmaco Riluzole Tablet Product Portfolio
- 7.4.5 Italfarmaco Recent Developments
- 7.5 Lunan Pharma
- 7.5.1 Lunan Pharma Company Information
- 7.5.2 Lunan Pharma Business Overview
- 7.5.3 Lunan Pharma Riluzole Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Lunan Pharma Riluzole Tablet Product Portfolio
- 7.5.5 Lunan Pharma Recent Developments
- 7.6 Mylan Pharma
- 7.6.1 Mylan Pharma Company Information
- 7.6.2 Mylan Pharma Business Overview
- 7.6.3 Mylan Pharma Riluzole Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Mylan Pharma Riluzole Tablet Product Portfolio
- 7.6.5 Mylan Pharma Recent Developments
- 7.7 Sanofi
- 7.7.1 Sanofi Company Information
- 7.7.2 Sanofi Business Overview
- 7.7.3 Sanofi Riluzole Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Sanofi Riluzole Tablet Product Portfolio
- 7.7.5 Sanofi Recent Developments
- 7.8 Sun Pharma
- 7.8.1 Sun Pharma Company Information
- 7.8.2 Sun Pharma Business Overview
- 7.8.3 Sun Pharma Riluzole Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Sun Pharma Riluzole Tablet Product Portfolio
- 7.8.5 Sun Pharma Recent Developments
8 North America
- 8.1 North America Riluzole Tablet Market Size by Type
- 8.1.1 North America Riluzole Tablet Revenue by Type (2021-2032)
- 8.1.2 North America Riluzole Tablet Sales by Type (2021-2032)
- 8.1.3 North America Riluzole Tablet Price by Type (2021-2032)
- 8.2 North America Riluzole Tablet Market Size by Application
- 8.2.1 North America Riluzole Tablet Revenue by Application (2021-2032)
- 8.2.2 North America Riluzole Tablet Sales by Application (2021-2032)
- 8.2.3 North America Riluzole Tablet Price by Application (2021-2032)
- 8.3 North America Riluzole Tablet Market Size by Country
- 8.3.1 North America Riluzole Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Riluzole Tablet Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Riluzole Tablet Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Riluzole Tablet Market Size by Type
- 9.1.1 Europe Riluzole Tablet Revenue by Type (2021-2032)
- 9.1.2 Europe Riluzole Tablet Sales by Type (2021-2032)
- 9.1.3 Europe Riluzole Tablet Price by Type (2021-2032)
- 9.2 Europe Riluzole Tablet Market Size by Application
- 9.2.1 Europe Riluzole Tablet Revenue by Application (2021-2032)
- 9.2.2 Europe Riluzole Tablet Sales by Application (2021-2032)
- 9.2.3 Europe Riluzole Tablet Price by Application (2021-2032)
- 9.3 Europe Riluzole Tablet Market Size by Country
- 9.3.1 Europe Riluzole Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Riluzole Tablet Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Riluzole Tablet Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Riluzole Tablet Market Size by Type
- 10.1.1 China Riluzole Tablet Revenue by Type (2021-2032)
- 10.1.2 China Riluzole Tablet Sales by Type (2021-2032)
- 10.1.3 China Riluzole Tablet Price by Type (2021-2032)
- 10.2 China Riluzole Tablet Market Size by Application
- 10.2.1 China Riluzole Tablet Revenue by Application (2021-2032)
- 10.2.2 China Riluzole Tablet Sales by Application (2021-2032)
- 10.2.3 China Riluzole Tablet Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Riluzole Tablet Market Size by Type
- 11.1.1 Asia Riluzole Tablet Revenue by Type (2021-2032)
- 11.1.2 Asia Riluzole Tablet Sales by Type (2021-2032)
- 11.1.3 Asia Riluzole Tablet Price by Type (2021-2032)
- 11.2 Asia Riluzole Tablet Market Size by Application
- 11.2.1 Asia Riluzole Tablet Revenue by Application (2021-2032)
- 11.2.2 Asia Riluzole Tablet Sales by Application (2021-2032)
- 11.2.3 Asia Riluzole Tablet Price by Application (2021-2032)
- 11.3 Asia Riluzole Tablet Market Size by Country
- 11.3.1 Asia Riluzole Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Riluzole Tablet Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Riluzole Tablet Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Riluzole Tablet Market Size by Type
- 12.1.1 SAMEA Riluzole Tablet Revenue by Type (2021-2032)
- 12.1.2 SAMEA Riluzole Tablet Sales by Type (2021-2032)
- 12.1.3 SAMEA Riluzole Tablet Price by Type (2021-2032)
- 12.2 SAMEA Riluzole Tablet Market Size by Application
- 12.2.1 SAMEA Riluzole Tablet Revenue by Application (2021-2032)
- 12.2.2 SAMEA Riluzole Tablet Sales by Application (2021-2032)
- 12.2.3 SAMEA Riluzole Tablet Price by Application (2021-2032)
- 12.3 SAMEA Riluzole Tablet Market Size by Country
- 12.3.1 SAMEA Riluzole Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Riluzole Tablet Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Riluzole Tablet Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Riluzole Tablet Value Chain Analysis
- 13.1.1 Riluzole Tablet Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Riluzole Tablet Production Mode & Process
- 13.2 Riluzole Tablet Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Riluzole Tablet Distributors
- 13.2.3 Riluzole Tablet Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst